Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabies Vaccine (Human Diploid Cell) Immunization Schedules in Population Aged 10 to 60 Years
NCT07275645Phase 3Active, not recruiting
- Sponsor
- Ab&B Bio-tech Co., Ltd.
- Start
- Feb 2026
- Primary completion
- Nov 2026
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rabies virus inactivated antigen, B in rabies, sponsored by Ab&B Bio-tech Co., Ltd.. Started Feb 2026; status: active, not recruiting.
02
Drugs
rabies virus inactivated antigen, B
03
Conditions
rabies
Beyond the preview
Go deeper on NCT07275645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07275645.